Vanda Pharmaceuticals Inc. (FRA:VM4)

Vanda Pharmaceuticals Statistics

Total Valuation

FRA:VM4 has a market cap or net worth of EUR 288.98 million. The enterprise value is 75.74 million.

Market Cap	288.98M
Enterprise Value	75.74M

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	59.11M
Shares Outstanding	n/a
Shares Change (YoY)	+1.34%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	52.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.57
PB Ratio	1.04
P/TBV Ratio	1.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.40
EV / Sales	0.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.81

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.04.

Current Ratio	2.39
Quick Ratio	2.19
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.11
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.93% and return on invested capital (ROIC) is -116.68%.

Return on Equity (ROE)	-50.93%
Return on Assets (ROA)	-16.50%
Return on Invested Capital (ROIC)	-116.68%
Return on Capital Employed (ROCE)	-43.97%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	345,322
Profits Per Employee	-352,303
Employee Count	533
Asset Turnover	0.38
Inventory Turnover	7.29

Taxes

In the past 12 months, FRA:VM4 has paid 69.69 million in taxes.

Income Tax	69.69M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.43%
50-Day Moving Average	6.07
200-Day Moving Average	4.53
Relative Strength Index (RSI)	37.66
Average Volume (20 Days)	23

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.74

Income Statement

In the last 12 months, FRA:VM4 had revenue of EUR 184.06 million and -187.78 million in losses. Loss per share was -3.19.

Revenue	184.06M
Gross Profit	172.95M
Operating Income	-128.75M
Pretax Income	-118.09M
Net Income	-187.78M
EBITDA	-121.84M
EBIT	-128.75M
Loss Per Share	-3.19

Balance Sheet

The company has 224.72 million in cash and 10.75 million in debt, with a net cash position of 213.97 million.

Cash & Cash Equivalents	224.72M
Total Debt	10.75M
Net Cash	213.97M
Net Cash Per Share	n/a
Equity (Book Value)	278.66M
Book Value Per Share	4.72
Working Capital	172.13M

Cash Flow

In the last 12 months, operating cash flow was -93.21 million and capital expenditures -849,997, giving a free cash flow of -94.06 million.

Operating Cash Flow	-93.21M
Capital Expenditures	-849,997
Free Cash Flow	-94.06M
FCF Per Share	n/a

Margins

Gross margin is 93.96%, with operating and profit margins of -69.95% and -102.02%.

Gross Margin	93.96%
Operating Margin	-69.95%
Pretax Margin	-64.16%
Profit Margin	-102.02%
EBITDA Margin	-66.20%
EBIT Margin	-69.95%
FCF Margin	n/a

Dividends & Yields

FRA:VM4 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.34%
Shareholder Yield	-1.34%
Earnings Yield	-64.98%
FCF Yield	-32.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:VM4 has an Altman Z-Score of -0.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.17
Piotroski F-Score	2